Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Sara Radian-Sade"'
Autor:
Zehava Grossman, Jonathan M Schapiro, Itzchak Levy, Daniel Elbirt, Michal Chowers, Klaris Riesenberg, Karen Olstein-Pops, Eduardo Shahar, Valery Istomin, Ilan Asher, Bat-Sheva Gottessman, Yonat Shemer, Hila Elinav, Gamal Hassoun, Shira Rosenberg, Diana Averbuch, Keren Machleb-Guri, Zipi Kra-Oz, Sara Radian-Sade, Hagit Rudich, Daniela Ram, Shlomo Maayan, Nancy Agmon-Levin, Zev Sthoeger
Publikováno v:
PLoS ONE, Vol 9, Iss 1, p e86239 (2014)
BACKGROUND: Analysis of potentially different impact of Lopinavir/Ritonavir (LPV/r) on non-B subtypes is confounded by dissimilarities in the conditions existing in different countries. We retrospectively compared its impact on populations infected w
Externí odkaz:
https://doaj.org/article/91f105998b5c42459bdef32217e8d081
Autor:
Zehava Grossman, Boaz Avidor, Zohar Mor, Michal Chowers, Itzchak Levy, Eduardo Shahar, Klaris Riesenberg, Zev Sthoeger, Shlomo Maayan, Wei Shao, Margalit Lorber, Karen Olstein-Pops, Daniel Elbirt, Hila Elinav, Ilan Asher, Diana Averbuch, Valery Istomin, Bat Sheva Gottesman, Eynat Kedem, Shirley Girshengorn, Zipi Kra-Oz, Yonat Shemer Avni, Sara Radian Sade, Dan Turner, Frank Maldarelli
Publikováno v:
PLoS ONE, Vol 10, Iss 8, p e0135061 (2015)
HIV in Israel started with a subtype-B epidemic among men who have sex with men, followed in the 1980s and 1990s by introductions of subtype C from Ethiopia (predominantly acquired by heterosexual transmission) and subtype A from the former Soviet Un
Externí odkaz:
https://doaj.org/article/b76e283e086d4a769cc000bef17be1f3
Autor:
Ravit Bassal, Daniel Chemtob, Yonat Shemer-Avni, Rachel Shirazi, Yael Gozlan, Haim Ben-Zvi, Ella Mendelson, Dana G. Wolf, Sara Radian-Sade, Marina Wax, Zipi Kra-Oz, Aviya Rakovsky, Orna Mor, Licita Schreiber, Mary Bakhanashvili
Publikováno v:
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology. 101
Architect (AR) and Vidas (VD) fourth generation HIV screening immunoassays, which identify early stages of HIV infections, could have false positive results especially at low signal/cutoff (S/C) AR values. Geenius HIV1/2 (GS) is a specific confirmati
Autor:
Zev Sthoeger, Amnon Zung, Keren Mahlab-Guri, Daniel Elbirt, Serge Gradstein, Sara Radian-Sade, Ilan Asher
Publikováno v:
Journal of Asthma. 48:860-863
Ritonavir, a protease inhibitor (PI), is commonly used in the treatment of HIV-1 infection. It is a potent inhibitor of the hepatic cytochrome P450 superfamily. Therefore, its usage with other PI medications leads to significant increases in the leve
Autor:
Wei Shao, Eynat Kedem, Sara Radian Sade, Michal Chowers, Zehava Grossman, Karen Olstein-Pops, Margalit Lorber, Shirley Girshengorn, Shlomo Maayan, Dan Turner, Zev Sthoeger, Hila Elinav, Zohar Mor, Zipi Kra-Oz, Ilan Asher, Yonat Shemer Avni, Bat Sheva Gottesman, Valery Istomin, Frank Maldarelli, Eduardo Shahar, Diana Averbuch, Boaz Avidor, Itzchak Levy, Klaris Riesenberg, Daniel Elbirt
Publikováno v:
PLoS ONE
PLoS ONE, Vol 10, Iss 8, p e0135061 (2015)
PLoS ONE, Vol 10, Iss 8, p e0135061 (2015)
Background HIV in Israel started with a subtype-B epidemic among men who have sex with men, followed in the 1980s and 1990s by introductions of subtype C from Ethiopia (predominantly acquired by heterosexual transmission) and subtype A from the forme
Autor:
Daniel, Elbirt, Itzhak, Levy, Ilan, Asher, Keren, Mahlev-Guri, Shira, Rosenberg-Bezalet, Slava, Litachevsky, Sara, Radian-Sade, Zev, Sthoeger
Publikováno v:
Harefuah. 152(4)
During recent years, the use of antiretroviral therapy expanded beyond the treatment of HIV-infected patients. Since the outset of the HIV epidemic, antiretroviral drugs were also used for post-exposure prevention of HIV infection in health workers a
Autor:
Diana Averbuch, Karen Olstein-Pops, Nancy Agmon-Levin, Sara Radian-Sade, Valery Istomin, Bat-Sheva Gottessman, Michal Chowers, Shlomo Maayan, Zehava Grossman, Daniela Ram, Eduardo Shahar, Jonathan M. Schapiro, Daniel Elbirt, Hila Elinav, Zev Sthoeger, Keren Machleb-Guri, Itzchak Levy, H Rudich, Klaris Riesenberg, Shira Rosenberg, Zipi Kra-Oz, Gamal Hassoun, Yonat Shemer, Ilan Asher
Publikováno v:
PLoS ONE, Vol 9, Iss 1, p e86239 (2014)
PLoS ONE
PLoS ONE
Background Analysis of potentially different impact of Lopinavir/Ritonavir (LPV/r) on non-B subtypes is confounded by dissimilarities in the conditions existing in different countries. We retrospectively compared its impact on populations infected wi